Crossmark

Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury

Crossref DOI link: https://doi.org/10.1186/s13073-022-01108-9

Published Online: 2022-09-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hinze, Christian https://orcid.org/0000-0003-2526-1621
Kocks, Christine https://orcid.org/0000-0003-1749-3334
Leiz, Janna https://orcid.org/0000-0002-6531-7047
Karaiskos, Nikos

Boltengagen, Anastasiya

Cao, Shuang

Skopnik, Christopher Mark https://orcid.org/0000-0002-6089-4769
Klocke, Jan https://orcid.org/0000-0002-7723-9234
Hardenberg, Jan-Hendrik https://orcid.org/0000-0001-9548-2118
Stockmann, Helena https://orcid.org/0000-0002-0934-7620
Gotthardt, Inka https://orcid.org/0000-0001-6033-0093
Obermayer, Benedikt https://orcid.org/0000-0002-9116-630X
Haghverdi, Laleh

Wyler, Emanuel

Landthaler, Markus https://orcid.org/0000-0002-1075-8734
Bachmann, Sebastian

Hocke, Andreas C. https://orcid.org/0000-0002-6935-8612
Corman, Victor

Busch, Jonas

Schneider, Wolfgang

Himmerkus, Nina https://orcid.org/0000-0002-2910-6728
Bleich, Markus https://orcid.org/0000-0002-1745-2295
Eckardt, Kai-Uwe https://orcid.org/0000-0003-3823-0920
Enghard, Philipp https://orcid.org/0000-0002-7254-3931
Rajewsky, Nikolaus https://orcid.org/0000-0002-4785-4332
Schmidt-Ott, Kai M. https://orcid.org/0000-0002-7700-7142
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (SFB 1365, GRK 2318, FOR 2841, HI-2238/2-1, SFB-TR 84, B6 / Z1a, EN 924/5-1, RA 838/5-1, KA 5006/1-1, Gottfried Wilhelm Leibniz Prize)

Berlin Institute of Health (Focus Area Translational Vascular Biomedicine, COVID Startup funding)

Berlin University Alliance GC2 Global Health (Corona Virus Pre-Exploration Project)

Bundesministerium für Bildung und Forschung ((RAPID, Organo-Strat 01KX2021)

Dr. Werner Jackstädt-Stiftung
License Information

Text and Data Mining valid from 2022-09-09

Version of Record valid from 2022-09-09
More Information

Article History

Received: 11 January 2022

Accepted: 12 August 2022

First Online: 9 September 2022

Declarations

:

: Our study protocol was approved by Charité’s Ethics Committee (ethics approvals EA2/045/18 for post mortem kidney biopsies and EA4/026/18 for tumor-adjacent normal tissue) and was conducted by following the Declaration of Helsinki and Guidelines for Good Clinical Practice. Written informed consent was given by the next of kin before enrollment in our study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below